Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.43 -0.10 (-3.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

Eledon Pharmaceuticals (ELDN) Liabilities and Shareholders Equity (2013 - 2026)

Updated

Eledon Pharmaceuticals (ELDN) reported Liabilities and Shareholders Equity of $126.09 million for Q2 2026, down 13.0% from $144.91 million a year earlier and down 14.0% from the prior quarter.

Analysis

Eledon Pharmaceuticals (ELDN) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

At the end of FY2025, Eledon Pharmaceuticals posted Liabilities and Shareholders Equity of $169.01 million, down 4.7% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $177.41 million in FY2024 (+99.2%), $89.07 million in FY2023 (-4.0%), $92.79 million in FY2022 (-45.6%) and $170.55 million in FY2021 (-13.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q3 2024.
  • Year over year, Liabilities and Shareholders Equity has now declined in each of the last three quarters, with growth averaging 28.1% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2025 (growth of 99.6%); the low point was Q1 2023 (a decline of 49.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $146.67 million (Q1 2026), $169.01 million (Q4 2025) and $129.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Eledon Pharmaceuticals 287.49 Mn 287.49 Mn - 126.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 126.09 Mn
Mar 31, 2026 146.67 Mn
Dec 31, 2025 169.01 Mn
Sep 30, 2025 129.86 Mn
Jun 30, 2025 144.91 Mn
Mar 31, 2025 161.31 Mn
Dec 31, 2024 177.41 Mn
Sep 30, 2024 114.58 Mn
Jun 30, 2024 120.48 Mn
Mar 31, 2024 80.82 Mn
Dec 31, 2023 89.07 Mn
Sep 30, 2023 96.07 Mn
Jun 30, 2023 106.79 Mn
Mar 31, 2023 82.31 Mn
Dec 31, 2022 92.79 Mn
Sep 30, 2022 149.59 Mn
Jun 30, 2022 154.71 Mn
Mar 31, 2022 161.38 Mn
Dec 31, 2021 170.55 Mn
Sep 30, 2021 177.17 Mn
API Access

Eledon Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELDN&period=max&api_key=YOUR_API_KEY